ArticleAnimal bioscience2025
Preparation of two kinds of immunocastration vaccines and their immune effects on male goats.
Article in Animal bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectivePost-pubertal male goats exhibit undesirable behaviors (fighting, mounting) and reduced growth due to high testosterone, while traditional castration causes stress. Immunocastration offers a humane alternative. This study aimed to develop effective immunocastration vaccines.
methodsThe gonadotropin-releasing hormone (GnRH) octamer vaccine (G8), luteinizing hormone receptor (LHR) and GnRH octamer tandem vaccine (LG) were developed and synthesized for this study. Forty 3-month-old male goats were randomly divided into four groups, and subjected to different treatments: surgical castration (SC group), immunization with the G8 vaccine (G8 group), immunization with the LG vaccine (LG group), or left intact (non-castration [NC] group). After the first immunization, serum antibodies and testosterone levels, as well as body weight, body size, and scrotal size, were measured at various time points. Testicular size and slaughter rate were measured at the time of slaughter, 20 weeks after the first immunization.
resultsBoth vaccines effectively elicited the corresponding antibodies in male goats; the testosterone levels in the G8 and LG groups were significantly reduced compared to the NC group (p<0.01). Four weeks after the first immunization, this trend persisted throughout the experiment; the testicular organ index and size of the G8 group were significantly (p<0.05) smaller than those of NC group at slaughter. In comparison to the NC group, the seminiferous tubule diameter in the G8 and LG groups was significantly reduced (p<0.01), accompanied by a notable decrease in Leydig Cells and various stages of spermatogenic cells. Additionally, the weight gain of goats in the SC group was significantly lower than that of other groups two weeks after the first immunization (p<0.05).
conclusionThe two immunocastration vaccines developed in this study effectively inhibit the testicular development and spermatogenesis in male goats, leading to a reduction in testosterone levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.